Tablet formulation comprising semaglutide and a delivery agent
US9993430B2 · kind B2 · utility
14Cited by
6References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2013 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Jun 19, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.